Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort. https://www.bloomberg.com/news/articles/2026-10-08/alphabet-s-isomorphic-labs-in-funding-talks-for-at-least-40-billion-value?taid=6ac734ed7a4b4a000148c88d&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter